Public-domain · open source
OpenJurist
← 713 F.2d 335 - Nutrilab, Inc. v. Schweiker

Nutrilab, Inc. v. Schweiker’s Empirical Analysis

713 F.2d 335 · 1983

Citation profile

29
cited by 29 later decisions
1
states following
September 2018
most recently cited

7 federal appellate · 6 district · 2 state decisions

How this case has been cited

Cited by 29 later decisions — most recently September 2018 · most notably United States v. Undetermined Quantities of Bottles of an Article of Veterinary Drug (1994), 855 F. Supp. 534 - United States v. Kasz Enterprises, Inc. (1994)

7 federal appellate · 6 district · 2 state decisions

1701983199020002010decided

Later decisions citing this case, by decade. The current decade is in progress, and our corpus holds fewer opinions from the most recent years, so the latest bars are undercounted — not a real decline.

Relationships

Relies on United States v. Hohensee · National Nutritional Foods Ass'n v. Mathews · National Nutritional Foods Ass'n v. Food & Drug Administration · 218 F. Supp. 208 - United States v. an Article of Drug Consisting of 250 Jars · Fawcett v. Missouri Pacific Railroad

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 29 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. “[Ajrticles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease ... and articles ... intended to affect the structure or any function of the body____”
    2 later decisions quote this exact passage
  2. “In [ National Nutritional I ], the FDA attempted to regulate as drugs all vitamin and mineral products in excess of the upper limits of the U.S. Recommended Daily Allowances ('RDA'). To bring these products within the Section 321(g)(1)(B) drug definition, the FDA had to show that the manufacturer's intended use was for treatment of a disease. Because the hearing record disclosed no food or nutrition use of nutrients at such high levels, the FDA inferred that the products were intended for therapeutic use. The court found first, that a significant number of persons have indisputable nutritional need for potencies exceeding the upper limits; and second, that to find actual therapeutic intent under part B of Section 321(g)(1) requires something more than evidence of uselessness as a food for most people. 504 F.2d at 789 .”
    1 later decision quote this exact passage
  3. “(1) articles used for food or drink for man or other animals, (2) chewing gum, and (3) articles used for components of any such article.”
    1 later decision quote this exact passage

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.